![]() For now, still in its early stages, this potential is more than accounted for in its share price. Before you run out and buy this stock, keep in mind it’s many years away from coming even close to this level of success. Known as Glucowise, the company projects an annual market potential topping $15 billion. You can even use them to improve solar panel efficiency.īut a key end use may be in the health care space, and diabetes management (glucose monitors) in particular.Īs InvestorPlace’s Chris MacDonald wrote July 6, Meta Materials is making progress in producing a non-invasive glucose sensing system. So is using them to deice and defog Lidar cameras on self-driving vehicles. 5G reception enhancement is one such possible use. Metamaterials are fabricated to achieve electromagnetic properties. Yet, there is a plethora of possible end users for its advanced materials, known as metamaterials. Its operating business today isn’t generating much revenue. Meta Materials Has Potential, But the Price Isn’t RightĬheck out Meta Material’s most recent investor presentation and excitement over its long-term prospects makes sense. But today, it’s still trading at inflated prices and has plenty more room to fall. It may be able to turn its technology into high levels of growth in the coming years. There may be opportunity down the road with the now-named MMAT stock. Others are likely holding the bag, hoping for a recovery.Ī recovery isn’t likely to happen any time soon. Those who got in near or at its split-adjusted high of $10.88 per share? Some likely got out early enough to cut their losses. Traders who got in at the start of the squeeze may have been able to cash out for fast profits near the top. As one Seeking Alpha contributor detailed near the peak of the squeeze, the former TRCH stock struck while the iron was hot, launching a dilutive secondary offering. So has another factor: the heavy issuance of new shares. This has driven much of this stock’s post-merger decline. 7 of the Best Contrarian Stocks to Buy as Others Get Greedyīut now, that trend’s come and gone once again.As you likely know, last month saw a mad dash into heavily shorted stocks, as retail traders tried to get in early on the next AMC Entertainment (NYSE: AMC) or GameStop (NYSE: GME). At the time, nearly a quarter of its free float was sold short. What was it that made this one of the hottest names among traders active online? Mostly, its potential as a short-squeeze play. For now? Hold off, as its sell-off is likely far from over. ![]() This may end up being a big winner down the road. ![]() There’s plenty here that could excite investors once again. Its biggest area of opportunity is a diabetes management product targeting a multi-billion dollar market. Existing areas of focus include 5G, self-driving cars and solar energy. With many applications for its technology, the company has big opportunities across many sectors. ![]() This sell-off will likely carry on, at least until its past meme stock status fully goes away.Īt a low enough price, it may be a worthwhile bet. Over the past month, it’s fallen from around $10 to less than $4 per share. ![]() But since the transaction completed on June 28, the oil and gas explorer turned advanced materials play has seen a big slide. ![]()
0 Comments
Leave a Reply. |